BEDFORD, Mass., July 20, 2011 – iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, and InTouch Health, a leading remote presence telemedicine solution provider, announced the signing of a joint development and licensing agreement to explore potential opportunities for healthcare applications on iRobot platforms such as the iRobot Ava mobile robotics platform. InTouch Health and its founder Yulun Wang have been pioneers in both the use of robots in hospitals and various remote presence technologies. The agreement includes extensive cross-licensing of the companies’ patent portfolios, giving the collaboration a formidable patent position.
“I am very excited about this agreement with InTouch Health, a company with a proven technology that delivers practical robotic solutions in the healthcare market. Together, we will revolutionize how people communicate and deliver information through remote presence,” said Colin Angle, chairman and CEO of iRobot.
“We are looking forward to teaming with iRobot. This agreement allows us to explore ways to address the needs of our rapidly growing market,” said Yulun Wang, founder and CEO of InTouch Health. “Together with iRobot, a world leader in practical robots, we will collaborate on the development of ground-breaking new technologies for the healthcare market.”
About iRobot Corp.
iRobot designs and builds robots that make a difference. The company’s home robots help people find smarter ways to clean, and its government and industrial robots protect those in harm’s way. iRobot’s consumer and military robots feature iRobot Aware® robot intelligence systems, proprietary technology incorporating advanced concepts in navigation, mobility, manipulation and artificial intelligence. For more information about iRobot, please visit www.irobot.com.
About InTouch InTouch
Health provides comprehensive telemedicine solutions and expertise that enable physicians to perform real-time consults with patients. Through a single portal, physicians can access a host of purpose-built, FDA-cleared telemedicine devices to provide care anywhere across the continuum: homes, clinics, ambulances, procedure rooms, EDs, ICUs, and patient wards. The InTouch Health Remote Presence telemedicine network is powered through its SureConnect® cloud-based infrastructure providing unparalleled connection quality and reliability, interoperability, workflow imaging and documentation, and services and support. Wherever access to medical expertise is limited, InTouch Health's Remote Presence telemedicine solutions can effectively extend the physician's reach to manage patient care, thereby removing critical time and distance barriers. The Company has more than 400 hospital locations on six continents enrolled in its Remote Presence network for the delivery of telemedicine services such as stroke, critical care, cardiology, trauma, pediatrics, neonatology, psychiatry, language translation, and clinical education and surgical/procedure mentoring. For more information about InTouch Health, please visit www.intouchhealth.com.
For iRobot Investors
Certain statements made in this press release that are not based on historical information are forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, iRobot Corp.’s expectations concerning management's plans, objectives and strategies. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. iRobot Corp. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise. For additional disclosure regarding these and other risks faced by iRobot Corp., see the disclosure contained in our public filings with the Securities and Exchange Commission including, without limitation, our most recent Annual Report on Form 10-K.
Contact:
Elise Caffrey
Investor Relations
iRobot Corp.
(781) 430-3003
ecaffrey@irobot.com
Charlie Vaida
Media Relations
iRobot Corp.
(781) 430-3182
cvaida@irobot.com
